Item Type | Name |
Academic Article
|
Comprehensive genomic characterization of squamous cell lung cancers.
|
Academic Article
|
Identification of common prognostic gene expression signatures with biological meanings from microarray gene expression datasets.
|
Academic Article
|
Prognostically relevant gene signatures of high-grade serous ovarian carcinoma.
|
Concept
|
Gene Expression Profiling
|
Academic Article
|
Comprehensive molecular characterization of clear cell renal cell carcinoma.
|
Academic Article
|
The Cancer Genome Atlas Pan-Cancer analysis project.
|
Academic Article
|
The somatic genomic landscape of glioblastoma.
|
Academic Article
|
Comprehensive molecular characterization of human colon and rectal cancer.
|
Academic Article
|
Integrated genomic analyses of ovarian carcinoma.
|
Academic Article
|
Tumor subtype-specific cancer-testis antigens as potential biomarkers and immunotherapeutic targets for cancers.
|
Academic Article
|
Tissue-specific isoform switch and DNA hypomethylation of the pyruvate kinase PKM gene in human cancers.
|
Academic Article
|
Transcriptional regulation of mitotic genes by camptothecin-induced DNA damage: microarray analysis of dose- and time-dependent effects.
|
Academic Article
|
High-Throughput GoMiner, an 'industrial-strength' integrative gene ontology tool for interpretation of multiple-microarray experiments, with application to studies of Common Variable Immune Deficiency (CVID).
|
Academic Article
|
Mutation analysis of 24 known cancer genes in the NCI-60 cell line set.
|
Academic Article
|
A stromal gene signature associated with inflammatory breast cancer.
|
Academic Article
|
Predicting cisplatin and trabectedin drug sensitivity in ovarian and colon cancers.
|
Academic Article
|
Evaluation of current methods used to analyze the expression profiles of ATP-binding cassette transporters yields an improved drug-discovery database.
|
Academic Article
|
Concordance of gene expression and functional correlation patterns across the NCI-60 cell lines and the Cancer Genome Atlas glioblastoma samples.
|
Academic Article
|
Apoptotic susceptibility of cancer cells selected for camptothecin resistance: gene expression profiling, functional analysis, and molecular interaction mapping.
|
Academic Article
|
Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays.
|
Academic Article
|
Comparing cDNA and oligonucleotide array data: concordance of gene expression across platforms for the NCI-60 cancer cells.
|
Academic Article
|
Workshop on cancer biometrics: identifying biomarkers and surrogates of cancer in patients: a meeting held at the Masur Auditorium, National Institutes of Health.
|
Academic Article
|
The p53 tumor suppressor network is a key responder to microenvironmental components of chronic inflammatory stress.
|
Academic Article
|
Spotlight on molecular profiling: "Integromic" analysis of the NCI-60 cancer cell lines.
|
Academic Article
|
Connecting genes, drugs and diseases.
|
Academic Article
|
Integrating global gene expression and radiation survival parameters across the 60 cell lines of the National Cancer Institute Anticancer Drug Screen.
|
Academic Article
|
VennMaster: area-proportional Euler diagrams for functional GO analysis of microarrays.
|
Academic Article
|
Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters.
|
Academic Article
|
AMPKa modulation in cancer progression: multilayer integrative analysis of the whole transcriptome in Asian gastric cancer.
|
Academic Article
|
Three microarray platforms: an analysis of their concordance in profiling gene expression.
|
Academic Article
|
Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study.
|
Academic Article
|
The LeFE algorithm: embracing the complexity of gene expression in the interpretation of microarray data.
|
Academic Article
|
mRNA and microRNA expression profiles of the NCI-60 integrated with drug activities.
|
Academic Article
|
RedundancyMiner: De-replication of redundant GO categories in microarray and proteomics analysis.
|
Academic Article
|
Functional categories associated with clusters of genes that are co-expressed across the NCI-60 cancer cell lines.
|
Academic Article
|
An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance.
|
Academic Article
|
Impact of p53 knockout and topotecan treatment on gene expression profiles in human colon carcinoma cells: a pharmacogenomic study.
|
Academic Article
|
Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells.
|
Academic Article
|
A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery.
|
Academic Article
|
GoMiner: a resource for biological interpretation of genomic and proteomic data.
|
Academic Article
|
Development of gene ontology tool for biological interpretation of genomic and proteomic data.
|
Academic Article
|
The bioinformatics of microarray gene expression profiling.
|
Academic Article
|
Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells.
|
Academic Article
|
Genes suppressed by DNA methylation in non-small cell lung cancer reveal the epigenetics of epithelial-mesenchymal transition.
|
Academic Article
|
Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities.
|
Academic Article
|
TANRIC: An Interactive Open Platform to Explore the Function of lncRNAs in Cancer.
|
Academic Article
|
Long non-coding RNA profiling links subgroup classification of endometrioid endometrial carcinomas with trithorax and polycomb complex aberrations.
|
Academic Article
|
A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations.
|
Academic Article
|
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers.
|
Academic Article
|
A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition.
|
Academic Article
|
Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use.
|
Academic Article
|
Integrated transcriptomic-genomic tool Texomer profiles cancer tissues.
|
Academic Article
|
Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer.
|
Academic Article
|
Assessment of Luminal and Basal Phenotypes in Bladder Cancer.
|